Efficiency of application of metformin and its combination with combined oral ontrceptive, containing drospirenone, in women with polycystic ovary syndrome
- Authors: Soboleva Y.L.1
-
Affiliations:
- D. O. Ott Research Institute of Obstetrics and Gynecology, RAMS
- Issue: Vol 62, No 4 (2013)
- Pages: 55-60
- Section: Articles
- URL: https://bakhtiniada.ru/jowd/article/view/2607
- DOI: https://doi.org/10.17816/JOWD62455-60
- ID: 2607
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Yelena Leonidovna Soboleva
D. O. Ott Research Institute of Obstetrics and Gynecology, RAMS
Email: doclena@inbox.ru
MD, Senior research associate, Reproductive Endocrinology Department
References
- Геворкян М. А. Эндокринно-метаболические и молекулярно-биологические факторы в восстановлении репродуктивного здоровья у женщин с синдромом поликистозных яичников: автореф. дис… д-ра. мед. наук. — М., 2001.
- Распространенность и клиническая картина синдрома поликистозных яичников в популяции Москвы / И. И. Дедов [и др.] // Проблемы эндокринологии. — 2010. — Т. 56, № 4. — С. 3–8.
- Чеботникова Т. В., Мельниченко Г. А. Перименопауза при СПКЯ // Проблемы репродукции. — 2007. — № 3. — С. 50–56.
- Шевцова В. Л. Клиническое значение эндокринно-метаболических нарушенией при синдроме поликистозных яичников и оптимизация методов их терапии: автореф. дис… канд. мед. наук. — М., 2006. — 23 с.
- Characteristics of glucose metabolism in non-obese and obese women withpolycystic ovarian syndrome / Y. H. Shi [et al.] // Zhonghua Fu Chan Ke Za Zhi. — 2010. — Vol. 45, N 8. — P. 575–577.
- Correlation of hyperandrogenism with hyperinsulinemia in PCOD / G. A. Burghen [et al.] // J. Clin. Endocrinol. Metab. — 1980. — Vol. 50. — P. 113–115.
- Glucose intolerance in polycystic ovary syndrome — a position statement of the Androgen Excess Society / K. E. Salley [et al.] // J. Clin. Endocrinol. Metab. — 2007. — Vol. 92, N 12. — P. 4546–4556.
- Kazerooni T., Dehghan-Kooshkghazi M. Effects of metformin therapy on hyperandrogenism in women with polycystic ovary syndrome // Gynecol. Endocrinol. — 2003. — Vol. 17, N 1. — P. 51–56.
- Lord J. M., Flight I. H., Norman R. J. Metformin in polycystic ovary syndrome: systematic review and meta-analysis // BMJ. — 2003. — Vol. 327, N 7421. — P. 951–953.
- Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome / L. C. Morin-Papunen [et al.] // Fertil. Steril. — 1998. — Vol. 69, N 4. — P. 691–696.
- Metformin-induced resumption of normal menses in 39 of 43 (91 %) previously amenorrheic women with the polycystic ovary syndrome / C. J. Glueck [et al.] // Metabolism. — 1999. — Vol. 48, N 4. — P. 511–519.
- Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation / P. Moghetti [et al.] // J. Clin. Endocrinol. Metab. — 2002. — Vol. 85, N 1. — P. 139–146.
- Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review / M. Costello [et al.] // Hum. Reprod. — 2007. — Vol. 22, N 5. — P. 1200–1209.
- Мetformin and glitazones: do they really help PCOS patients / A. Pillai [et al.] // Fam. Pract. — 2007. — Vol. 56, N 6. — P. 444–453.
- Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women / R. S. Legro [et al.] // J. Clin. Endocrino. l. Metab. — 1999. — Vol. 84, N 1. — P. 165–169.
- Prevalence of impaired glucose tolerance and diabetes in women with polycysticovary syndrome / D. A. Ehrmann [et al.] // Diabetes Care. — 1999. — Vol. 22. — P. 141–146.
- Rotterdam ESHRE/ASRM-Sponsored Consensus Workshop Group 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome // Hum. Reprod. — 2004. — Vol. 19, N1. — P. 41–47.
Supplementary files
